By drug class, the triple agonists (Pipeline) segment held a 3% share of the market in 2025 and is expected to grow at the fastest CAGR of 29.4% during the projection period
It assists in blood sugar control and potentially supports weight loss
FDA labeling for both drugs explicitly frames them as adjuncts to diet and physical activity, not as stand-alone solutions
Some users split the dosage into morning and evening administrations for more consistent peptide exposure
HC Pedroches: Jeannet Snchez Ypez, Mercedes del Pilar Fernndez Girn, Beatriz Lpez Serrano, M Teresa Rodrguez Monje, Paloma Morso Pelaez, Mara Cortes Duran, Carolina Lpez Olmeda, Almudena Garca- Uceda Sevilla, Dolores Serrano Gonzlez, Inmaculada Santamara Lpez
For many, traditional weight loss methods fail to provide long-term results